Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Update kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Marquette Asset Management LLC purchased a new position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 27,867 shares of the company’s stock, valued at approximately $92,000. Other hedge funds have also recently added to […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) has earned an average rating of “Hold” from the eight research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and four have issued a buy recommendation on the company. […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 3,740,000 shares, a growth of 5.1% from the August 31st total of 3,560,000 shares. Based on an average daily volume of 2,060,000 shares, the short-interest ratio […]
CAMBRIDGE - Fulcrum Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management.